Supplemental Tables 1 and 2 (16–21,27–51) summarize the published literature on the utility of PET/CT imaging using different PSMA-directed radiotracers, including 12 articles on 18F-based tracers (18F-DCFPyL, 18F-PSMA-1007) and 19 articles on 68Ga-based tracers (68Ga-PSMA-11, 68Ga-P16–093), in patients with RCC (31 studies, including case reports and case series) (supplemental materials are available at http://jnm.snmjournals.org). This evidence concerns the gene FOLH1 and renal cell carcinoma.